We are live on ! Find out more
HWM

HighMark Wealth Management Portfolio holdings

AUM $246M
1-Year Est. Return 35.95%
This Fund
S&P 500
This Quarter Est. Return
-4.21%
1 Year Est. Return
+35.95%
3 Year Est. Return
+84.22%
5 Year Est. Return
+86.67%
10 Year Est. Return
–
AUM
$121M
AUM Growth
-$12.5M
Cap. Flow
-$6.4M
Cap. Flow %
-5.31%
Top 10 Hldgs %
74.38%
Holding
590
New
27
Increased
162
Reduced
81
Closed
24

Top Buys

Rank Stock Value
1
PRLB icon
Protolabs
PRLB
+$145K
2
SCTL
Societal CDMO, Inc. Common Stock
SCTL
+$111K
3
ATRC icon
AtriCure
ATRC
+$87.8K
4
TNDM icon
Tandem Diabetes Care
TNDM
+$78.8K
5
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$67.8K

Top Sells

Rank Stock Value
1
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$2.16M
2
KRYS icon
Krystal Biotech
KRYS
+$2.02M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$637K
4
EFV icon
iShares MSCI EAFE Value ETF
EFV
+$584K
5
HALO icon
Halozyme
HALO
+$430K

Sector Composition

Rank Sector Weight
1 Healthcare 7.9%
2 Financials 4.48%
3 Technology 3.39%
4 Consumer Discretionary 2.75%
5 Industrials 1.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARKK icon
526
ARK Innovation ETF
ARKK
$5.59B
$636 ﹤0.01%
16
– –
SGMO
527
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$600 ﹤0.01%
1,000
– –
OSUR icon
528
OraSure Technologies
OSUR
$273M
$593 ﹤0.01%
100
– –
CELL
529
DELISTED
PhenomeX Inc. Common Stock
CELL
$549 ﹤0.01%
550
– –
DFIN icon
530
Donnelley Financial Solutions
DFIN
$1.28B
$507 ﹤0.01%
9
– –
CLOU icon
531
Global X Cloud Computing ETF
CLOU
$236M
$480 ﹤0.01%
25
– –
TAC icon
532
TransAlta
TAC
$3.93B
$438 ﹤0.01%
50
– –
MARA icon
533
Marathon Digital Holdings
MARA
$3.83B
$425 ﹤0.01%
50
– –
AYX
534
DELISTED
Alteryx Inc
AYX
$377 ﹤0.01%
10
– –
TELL
535
DELISTED
Tellurian Inc.
TELL
$342 ﹤0.01%
295
– –
PEB icon
536
Pebblebrook Hotel Trust
PEB
$2.18B
$328 ﹤0.01%
24
– –
ALEC icon
537
Alector
ALEC
$169M
$324 ﹤0.01%
50
– –
AVT icon
538
Avnet
AVT
$6.86B
$299 ﹤0.01%
6
– –
TSVT
539
DELISTED
2seventy bio
TSVT
$298 ﹤0.01%
76
– –
CRBP icon
540
Corbus Pharmaceuticals
CRBP
$165M
$276 ﹤0.01%
41
– –
ARAY icon
541
Accuray
ARAY
$27.5M
$272 ﹤0.01%
100
– –
C icon
542
Citigroup
C
$213B
$236 ﹤0.01%
6
– –
ADAP
543
DELISTED
Adaptimmune Therapeutics
ADAP
$224 ﹤0.01%
287
-982
-77% -$824
SAVE
544
DELISTED
Spirit Airlines, Inc.
SAVE
$214 ﹤0.01%
13
– –
OUST icon
545
Ouster
OUST
$2.11B
$207 ﹤0.01%
41
– –
VMBS icon
546
Vanguard Mortgage-Backed Securities ETF
VMBS
$15.4B
$185 ﹤0.01%
4
– –
SLVM icon
547
Sylvamo
SLVM
$1.52B
$180 ﹤0.01%
4
– –
USIG icon
548
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$156 ﹤0.01%
3
– –
PRLD icon
549
Prelude Therapeutics
PRLD
$375M
$155 ﹤0.01%
50
– –
SPOT icon
550
Spotify
SPOT
$108B
$155 ﹤0.01%
1
– –
20 21
22
23 24

Similar funds

PPA
Pilgrim Partners Asia Singapore $246M AUM
IRP
Investment Research Partners Lemont, Pennsylvania $246M AUM
EPIM
Equinox Partners Investment Management Stamford, Connecticut $245M AUM 225.58% 1-Year Est. Return
MAMHA
MY.Alpha Management HK Advisors Hong Kong $246M AUM 73.75% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
CSC
Caldwell Sutter Capital Sausalito, California $246M AUM 23.62% 1-Year Est. Return
NTCM
Nut Tree Capital Management New York $245M AUM 34.1% 1-Year Est. Return
VPA
Vernal Point Advisors San Francisco, California $246M AUM 12.97% 1-Year Est. Return

HighMark Wealth Management's Q3 2023 Portfolio in Review

As of Q3 2023, HighMark Wealth Management held 590 positions worth $121M, down 9.4% from $133M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

HighMark Wealth Management withdrew a net $6.4M in Q3 2023, closing 24 positions and reducing 81 holdings. Its most notable exit was Reata Pharmaceuticals, Inc. Class A Common Stock, an estimated $2.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.9% of assets, down from 12% a quarter earlier, followed by Financials and Technology.

Against the trend, HighMark Wealth Management opened a new position in Insulet worth $19.9K.

  • HighMark Wealth Management's largest Q3 2023 buy was Insulet: 125 shares worth $19.9K.
  • HighMark Wealth Management added most to Protolabs in Q3 2023, an estimated $145K increase.
  • HighMark Wealth Management's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $637K.
  • HighMark Wealth Management fully exited Reata Pharmaceuticals, Inc. Class A Common Stock in Q3 2023, selling an estimated $2.16M.
  • HighMark Wealth Management's ten largest holdings make up 74% of its $121M portfolio in Q3 2023.
  • HighMark Wealth Management opened 27 new positions and closed 24 in Q3 2023.
  • HighMark Wealth Management's portfolio value fell 9.4% quarter-over-quarter to $121M.

Based on HighMark Wealth Management's 13F filing for Q3 2023, filed 18 Oct 2023.